Oraceuticals Inc. is engaged in the research, development, and commercialization of drugs and discovery that advance oral treatment, improve oral health, and enrich lives. The Company’s focus is anti-inflammatory, anti-microbial drug development, as well as diagnostics and bioinformatics. 

We are dedicated to utilize the latest biotechnologies to develop innovative oral health products, provide excellent research and scientific services, and seek worldwide collaboration to improve human oral health.

 

 

On March 1st, 2010, Dr. Huang, CEO of Oraceuticals became an award recipient of Kentucky SBIR-STTR       Matching Funds Program Grants.

Copyright © 2003-2011, Oraceuticals, Inc. All Rights Reserved.
Use of and access to the information on this site are subject to the terms and conditions set out in the Agreement to use the Oraceuticals web site.